ABSTRACT -Cytokines and intrathecal IgG synthesis were determined in the cerebrospinal fluid (CSF) and sera to evaluate inflammatory activity in multiple sclerosis (MS) patients during clinical remission. Although the disease was stable, there had been a significant increase of pro i n f l a m m a t o ry cytokines such as TNFα and IFNγ in the CSF and serum, with no significant changes of IL12 and IL10 production. The changes in t h e cytokine production patterns were associated with an increase of leukocytes in the CSF, as well as the pre sence of oligoclonal bands suggesting intrathecal IgG synthesis. These results suggest that even when the disease is clinically silent, one can observe inflammatory activity in these MS patients.
Multiple sclerosis (MS) is a disorder of the central nervous system (CNS) characterized by perivascular inflammation and demyelination in the white m a t t e r. The etiology and pathogenesis of MS is u nknown, although it is a complex phenomenon involving both genetic and environmental aspects. These forces interact to produce individual susceptibility to the disease and influence its course 1 . Although MS is a disease of the CNS, the peripheral blood and cere b rospinal fluid (CSF) of patients contain activated autoreactive T cells recognizing myelin components such as myelin basic protein ( M B P ) , p roteolipid protein (PLP), myelin associated glycop rotein and myelin oligodendrocyte glycopro t e i n ( M O G ) 2 . Activated T lymphocytes also produce cytokines that modulate the immune response either positively or negatively. Some of these cytokines have pro i n f l a m m a t o ry effects enhancing inflamm a t o ry reactions; whereas others have anti-inflamm a t o ry pro p e rties. The cytokines produced by Th1 cells, such as tumor necrosis factor alpha (TNFα) and interf e ron gamma (IFNγ), may promote the p ro g ress of the disease 3 , 4 , while those pro d u c e d by the Th2/Th3 subsets, such as interleukin 10 (IL10) and transforming growth factor beta (TGFβ), may limit it 5 . Some authors have also re p o rted the imp o rtant contribution of antibodies in the initiation of myelin sheath damage in MS 6 . For diagnosis, magnetic resonance imaging ( M R I ) has shown great potential as an indicator of disease activity in patients with MS 7 , with the use of CSF analysis receiving less attention. However, the CSF analysis is still a valuable tool and in association w i t h imaging data provide reliable information about the inflammatory status of a patient.
CYTOKINES AND INTRATHECAL IgG SYNTHESIS IN MULTIPLE SCLEROSIS PATIENTS DURING CLINICAL REMISSION
In the present study, we assessed serum and CSF levels of cytokines, leukocytes count and intrathecal IgG synthesis to evaluate inflammatory activit y in a subgroup of untreated MS Brazilian patients during clinical remission.
METHOD
Patients -Patients were re c ruited at the hospital of the University of Campinas, located in Campinas, SP, Brazil, during the period of [2002] [2003] [2004] . A total of 58 individuals (42 women and 16 men) were included in the stud y. At that time, the individuals were divided into thre e g roups: I. 23 clinically definite MS patients (6 men, 17 women, the mean age was 30) with a re l a p s i n g -re m i t t i n g f o rm of disease (RRMS) according to Poser criteria 8 ; II. 16 patients with other neurologic diseases (3 men, 13 women, the mean age was 33): 4 with motor neuron disease, 2 with here d i t a ry sensory-motor neuro p a t h y, 2 with Parkinson´s disease, 4 with epilepsy, 2 Alzheimer´s disease, 2 with cere b rovascular disease; III. 19 individuals (7 men, 12 women, the mean age was 31 years) with backache or headache and who had no evidence of organic neuro l o gical disease, studied as a healthy control group. The patients with clinically definite MS who were seen in our MS clinic were studied. MRI and laboratory investigations w e re perf o rmed during the initial contact for diagnosis purposes and the determination that the patients were in remission, without treatment. The delay between first attack and first consultation was 4.2 ± 3.8 years. The Expanded Disability Status Scale (EDSS) score was determ i n e d at lumbar puncture. None of the patients had re c e i v e d c o rt i c o s t e roids or other immunosuppressive drugs during a period of at least 6 months prior to donating CSF and blood for the study. The study was approved by the Medical Ethics Committee of the hospital, and inform e d consent was obtained.
Samples -All specimens were obtained for the ro utine determination of CSF leukocyte count, IgG synthesis and oligoclonal IgG bands. Paired samples of seru m and CSF were stored at -80 o C until these exams were p e rf o rmed. The CSF (10 mL) was taken and cell counting done quickly before sampling.
L a b o r a t o ry pro c e d u res -IgG and albumin in the CSF
and serum were measured by nephelometry (BNII; Dade Behring, Marburg, Germany), and Link Indexes (LI) were calculated according to the literature 9 . Oligoclonal IgG bands were identified by isoelectrofocusing 10 .
Antigen, antibody and recombinant cytokines -T h e IL12, IFNγ, TNFα, and IL10 were quantified using comm e rcial kits from Biosource International, Nivelles, Belgium. All measure was made at the single occasion in o rder to minimize the intra assay variability. Briefly, 96-well microtiter plates were coated with 1-2 ρg/mL of c a p t u re monoclonal antibody for each cytokine in 0.1M N a H C O 3 (pH= 8.5) and allowed to incubate overn i g h t at 4 o C. Following blocking with 3% dry milk in PBS at room temperature for 2 h, samples and standard re c o mbinant IFNγ, TNFα, IL10 and IL12 were added again and incubated overnight at 4º C. Then, 0.5-2.0 ρg/mL of biotinylated detection monoclonal antibody for human IL12, IFNγ, TNFα and IL10 were added, followed by the addition of avidin-peroxidase 1/400 (Sigma Chem.-USA) and the peroxidase substrate. A stop solution was used to obtain OD determined at 492 nm.
Imaging -MRIs were perf o rmed, using a 2.0 Te s l a s y stem (Elscint, Pre s t i g e R ). All exams covered the whole brain using 6.0 mm slice thick and 1.2 mm inter-s l i c e gap. MRI acquisition parameters for images used for analysis were: T1 sagittal images and T2 axial.
Statistics -The statistical significance of the results was d e t e rmi ned using a non-parametric analysis of variance, and a Kru s k a l -Wallis test and Spearman Rank test. A p v a lue smaller than 0.05 was considered to be significant.
RESULTS
Twenty three patients with MS were evaluated (Table 1 ). Brain MRI showed abnormalities with demyelinating lesions in 23 (100 %) and pre s e n c e of gadolinium-enhancing lesions in 5 (21 %) of the 23 MS patients. These patients showed CSF hypercytosis and intrathecal IgG synthesis. Twenty-one (91.3 %) MS patients were oligoclonal bands (OCB) positive.
CSF data and patients characteristics of the g roups are shown in Table 2 . The percentage of patients with hypercytosis was increased in the MS g roup when compared with the group II (other n e urologic diseases; p= 0.004) and group III (healthy controls; p= 0. 0001).
P roduction of TNFα in CSF and serum of patients with MS, other neurological disorders, as w e l l as healthy controls -
The means for MS patients w e re 137.3 ± 119.7 and 116.0 ± 115 pg/ml in seru m and CSF, respectively; whereas for the OND gro u p these were 7.6 ± 24.1 and 8.6 ± 28.4 pg/ml for serum and CSF, respectively; for the healthy contro l s , these values were 15.3 ± 19.8 and 4.3 ± 8.2 pg/ml. A significant increase (p<0.001) in TNFα was observed in the CSF, and serum of patients with MS.
T N Fαlevels in the CSF exceeded those in the seru m for 10/23 patients, suggesting an intrathecal synthesis (Fig 1A) . There was a positive corre l a t i o n between the number of leukocytes in the CSF and the level of TNFα (R 2 = 0.6874, p= 0.001).
Production of IL12p40 in CSF and serum -The means for MS patients were 49.1 ± 18.3 and 39.4 ± 13.2 pg/mL for serum and CSF, respectively; whereas for the OND group they were 76.2 ± 32.2 and 58.1 ± 35.1 pg/mL; for the healthy controls these means were 57.4 ± 18.8 and 45.4 ± 15.3 pg/mL. No significant diff e rence (p>0.05) were observed between the three groups (Fig 1 B) .
P roduction of IFNγ in CSF and serum patients with MS and, other neurological disorders, as well
as healthy contro l s -The means for MS patients w e re 500.9 ± 169.5 and 359.0 ± 85.1 pg/mL in serum and CSF respectively; whereas for the OND g roup, these were 418.6 ± 67.0 and 325.2 ± 70.5 pg/mL; for the healthy controls these mean were 102.6 ± 102.7 and 54.1 ± 39.6 pg/mL. A significant i n c rease (p< 0.001) in the IFNγ was observed in both CSF and serum of patients with both MS and OND ( Fig 1C) .
P roduction of IL-10 in CSF and serum -
The m e a n s for MS patients were 304.6 ± 112.0 and 287.6 ± 113.7 pg/mL for serum and CSF, respectively; whereas for the OND group they were 507.6 ± 187.1 and 424.3 ± 113.7 pg/mL for serum and CSF, re s p e ctively; for the healthy controls, these means were 354.6 ± 111.4 and 296.2 ± 74.8 pg/mL. No significant diff e rences were found between the patients with MS and healthy controls (p>0.05), where a s the OND group of patients revealed significantly higher levels of IL 10 (p=0.006) (Fig 1D) .
DISCUSSION
The purpose of this investigation was to evaluate inflammatory activity in MS patients during clinical remission. Our results showed that patients with MS which is identified stable phase of the disease reveal increase in the secretion of pro -i n f l a mm a t o ry cytokines in both serum and CSF associated with the increase in the intrathecal synthesis of IgG and the number of leukocytes in the CSF. T h i s study demonstrated that patients with stable RRMS have an elevated number of leukocytes in the CSF when compared with patients with other non-inf l a m m a t o ry diseases of CNS and healthy contro l s . Other studies suggested that the presence of white blood cells in the CSF is a good predictor of the activity of MS, since after two years, patients with a high number of white blood cells in the CSF had more relapses than those in control group 11 .
Parallel to the increase of the number of cells there is also the presence of oligoclonal bands in 91% of studied MS patients. These results are in a g reement with previous Brazilian re p o rt s 1 2 , 1 3 . Although the antibody specificity in the oligoclonal bands is still enigmatic, as suggested by re p o rts in the literature, a lack of intrathecal synthesis of oligoclonal IgG bands is related to short lasting and benign course of MS 14 .
The B-cell proliferation, diff e rentiation and antibody production is coordinated by the helper T cells and the cytokines they produce. Although Th1 and Th2 cells are the major sources of their respective cytokines, many others cells within and outside the immune system also produce these cytokines, contributing to an overall Th1 and Th2 cytokine pattern. It was thus decided to quantify both pro and anti-inflammatory cytokines in the CSF and the serum, independent of their source.
The cytokines produced in the early phase of i n f l a m m a t o ry response, such as IL12, contribute to the development of Th1 immune response. Conflicting results re g a rding IL12 production have, h o w e v e r, been observed in MS. An increase in the production of this cytokine has been observed in progressive MS 15 and increased frequencies of IL-12 secreting monocytes appear to correlate with the presence of active brain lesions detected by M R I 1 6 . Serum levels of IL12, however, have been found to be similar in MS patients and controls 17 . In the present study, as well, no change in the production of this cytokine was observed in the seru m or CSF of MS patients. It seems that, blood monocytes must be stimulated in order to produce detectable amounts of IL12, but since we did not use activated cells, the production of IL12 may have been too low to be detected in the ELISA assay.
The IFNγ of MS patients, on the other hand, showed significant increase in the CSF and serum over that of healthy controls, although no diff e re nce was observed in relation to the OND group. Init i a l l y, interf e rons were tested as therapeutic agents for MS because of their antiviral pro p e rties and it was felt that MS might be due to persistent viral infection. However, a pathogenic role for MS patients who received recombinant IFNγ t re a t m e n t in MS has been re p o rt e d 1 8 . Our data support pre v ious ones which demonstrated that IFNγ has potent p ro i n f l a m m a t o ry response, including the ability to induce the production of other pro i n f l a m m a t ory cytokines 1 9 . In the animal model, the pro d u ct i o n of isotypes of IgG, such as IgG2a is induced by the I F Nγ. In our findings, no information is given about the subclass of IgG, which is increased in the CSF of MS patients, but it is possible that the incre a s e in intrathecal IgG production is due to the incre a s e in intrathecal synthesis of IFNγ.
In addition to the production of IFNγ, there was a parallel increase of TNFα in the serum and CSF. A p p roximately 40 % of the MS patients pre s e n t e d levels of TNFα in the CSF equal to or greater than that in the serum, suggesting the intrathecal synthesis of this cytokine. TNFα has been described as a major cytokine in this demyelinating disease, since it has been demonstrated to be myelinotoxic 2 0 -2 3 . T N Fα is also a major inducer of endothelial adhesion molecules and chemokines, hence, the upre g ulation TNFα may have a major effect on the re c ru i tment of leukocytes to the CNS 2 4 . In this study it was possible to show a positive correlation between the number of leukocytes in the CSF and the level of T N Fα. This pro p e rty may explain, at least in part, the i n c reased number of inflammation-perpetuating leukocytes observed in the CSF in MS patients. Elevation in CSF concentrations of soluble ICAM-1 and soluble TNFα receptor were demonstrated previously in Brazilian MS patients with acute re l a p sing form of MS during exacerbation 2 5 .
As the inflammatory response develops, the cytokine products of Th1 or Th2 lymphocytes pro v ide mutually inhibitory functions for the diff e re n t i ation and effector effect of the re c i p rocal phenotype. IFNγ p revent Th2 cell proliferation, whereas I L 1 0 p rofoundly inhibits the synthesis of Th1 cytokines 2 6 . Reports on the IL-10 production showed that patients with high IL-10 production had significantly lower disability scores and lower T2 lesion load 2 7 .
In the present study, we did not observe significant changes in IL10 levels in MS patients. These data agree with that of studies demonstrating a reduction in IL10 levels in the serum, as well as in the number of IL10-secreting cells in MS patie n t s 1 9 , 2 8 -3 0 , re i n f o rcing the fact that the pro i n f l a mm a t o ry response prevails in this group of patients, despite the absence of clinical manifestation.
This study provides evidence of a significant inc rease in inflammatory activity in patients with stable MS over that in the control groups. These observations suggest that an investigation of the inflammatory parameters in the CSF may provide a valuable tool, which would be useful in the indication of activity of the disease, thus helping understand the damages caused by the inflammatory response.
